China Universal Asset Management Co., Ltd. Atai Life Sciences N.V. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 32,273 shares of ATAI stock, worth $38,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,273

Previous 19,666 64.11%

Holding current value

$38,404

Previous $26,000 42.31%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$1.16 - $1.64 $14,624 - $20,675	12,607 Added 64.11%	32,273 $37,000
Q2 2024 Jul 19, 2024	SELL	$1.27 - $2.6 $15,535 - $31,805	-12,233 Reduced 38.35%	19,666 $26,000
Q1 2024 Apr 29, 2024	BUY	$1.5 - $2.19 $19,039 - $27,797	12,693 Added 66.09%	31,899 $63,000
Q4 2023 May 21, 2024	SELL	$1.04 - $1.55 $13,200 - $19,674	-12,693 Reduced 39.79%	19,206 $27,000
Q4 2023 Jan 23, 2024	BUY	$1.04 - $1.55 $15,545 - $23,169	14,948 Added 351.06%	19,206 $27,000
Q3 2023 May 21, 2024	BUY	$1.27 - $2.28 $2,645 - $4,749	2,083 Added 95.77%	4,258 $5,000
Q3 2023 Oct 30, 2023	BUY	$1.27 - $2.28 $2,645 - $4,749	2,083 Added 95.77%	4,258 $5,000
Q2 2023 May 21, 2024	SELL	$1.44 - $2.19 $105 - $159	-73 Reduced 3.25%	2,175 $3,000
Q2 2023 Jul 27, 2023	SELL	$1.44 - $2.19 $105 - $159	-73 Reduced 3.25%	2,175 $4,000
Q1 2023 May 21, 2024	BUY	$1.17 - $2.7 $658 - $1,520	563 Added 33.41%	2,248 $4,000
Q1 2023 Apr 27, 2023	BUY	$1.17 - $2.7 $658 - $1,520	563 Added 33.41%	2,248 $4,000
Q4 2022 May 21, 2024	SELL	$2.38 - $3.55 $71,909 - $107,259	-30,214 Reduced 94.72%	1,685 $4,000
Q4 2022 Jan 31, 2023	BUY	$2.38 - $3.55 $404 - $603	170 Added 11.22%	1,685 $4,000
Q3 2022 Oct 21, 2022	BUY	$3.14 - $4.87 $4,757 - $7,378	1,515 New	1,515 $5,000

Others Institutions Holding ATAI

# of Institutions

Shares Held

12.4M

Call Options Held

77.8K

Put Options Held

50.3K

View Full List

About ATAI Life Sciences N.V.

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

More about ATAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Atai Life Sciences N.V. Transaction History